33 related articles for article (PubMed ID: 15268981)
1. Salinization Dramatically Enhance the Anti-Prostate Cancer Efficacies of AR/AR-V7 and Mnk1/2 Molecular Glue Degraders, Galeterone and VNPP433-3β Which Outperform Docetaxel and Enzalutamide in CRPC CWR22Rv1 Xenograft Mouse Model.
Thankan RS; Thomas E; Purushottamachar P; Weber DJ; Njar VCO
Bioorg Chem; 2023 Oct; 139():106700. PubMed ID: 37392559
[TBL] [Abstract][Full Text] [Related]
2. Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis.
Gunawardana M; Remedios-Chan M; Sanchez D; Webster S; Castonguay AE; Webster P; Buser C; Moss JA; Trinh M; Beliveau M; Hendrix CW; Marzinke MA; Tuck M; Caprioli RM; Reyzer ML; Kuo J; Gallay PA; Baum MM
Sci Rep; 2022 May; 12(1):8224. PubMed ID: 35581262
[TBL] [Abstract][Full Text] [Related]
3. Drug-Like Properties in Macrocycles above MW 1000: Backbone Rigidity versus Side-Chain Lipophilicity.
Furukawa A; Schwochert J; Pye CR; Asano D; Edmondson QD; Turmon AC; Klein VG; Ono S; Okada O; Lokey RS
Angew Chem Int Ed Engl; 2020 Nov; 59(48):21571-21577. PubMed ID: 32789999
[TBL] [Abstract][Full Text] [Related]
4. A Rapid UPLC-MS Method for Quantification of Gomisin D in Rat Plasma and Its Application to a Pharmacokinetic and Bioavailability Study.
Zheng X; Feng F; Jiang X; Qiu J; Cai X; Xiang Z
Molecules; 2019 Apr; 24(7):. PubMed ID: 30974748
[TBL] [Abstract][Full Text] [Related]
5. VN/14-1 induces ER stress and autophagy in HP-LTLC human breast cancer cells and has excellent oral pharmacokinetic profile in female Sprague Dawley rats.
Godbole AM; Ramalingam S; Ramamurthy VP; Khandelwal A; Bruno RD; Upreti VV; Gediya LK; Purushottamachar P; Mbatia HW; Addya S; Ambulos N; Njar VC
Eur J Pharmacol; 2014 Jul; 734():98-104. PubMed ID: 24726842
[TBL] [Abstract][Full Text] [Related]
6. Nonlinear absorption kinetics of self-emulsifying drug delivery systems (SEDDS) containing tocotrienols as lipophilic molecules: in vivo and in vitro studies.
Alqahtani S; Alayoubi A; Nazzal S; Sylvester PW; Kaddoumi A
AAPS J; 2013 Jul; 15(3):684-95. PubMed ID: 23572242
[TBL] [Abstract][Full Text] [Related]
7. Exploring indirect sources of human exposure to perfluoroalkyl carboxylates (PFCAs): evaluating uptake, elimination, and biotransformation of polyfluoroalkyl phosphate esters (PAPs) in the rat.
D'eon JC; Mabury SA
Environ Health Perspect; 2011 Mar; 119(3):344-50. PubMed ID: 21059488
[TBL] [Abstract][Full Text] [Related]
8. The biological and clinical role of drug transporters at the intestinal barrier.
Oostendorp RL; Beijnen JH; Schellens JH
Cancer Treat Rev; 2009 Apr; 35(2):137-47. PubMed ID: 18986769
[TBL] [Abstract][Full Text] [Related]
9. Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. II. Studies implicating transporter-mediated intestinal secretion.
Ward KW; Hardy LB; Kehler JR; Azzarano LM; Smith BR
Xenobiotica; 2004 Apr; 34(4):367-77. PubMed ID: 15268981
[TBL] [Abstract][Full Text] [Related]
10. Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. I. Investigation of potential experimental and mechanistic explanations.
Ward KW; Azzarano LM; Evans CA; Smith BR
Xenobiotica; 2004 Apr; 34(4):353-66. PubMed ID: 15268980
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a potential transporter-mediated drug interaction between rosuvastatin and pradigastat, a novel DGAT-1 inhibitor.
Kulmatycki K; Hanna I; Meyers D; Salunke A; Movva A; Majumdar T; Natrillo A; Vapurcuyan A; Rebello S; Sunkara G; Chen J
Int J Clin Pharmacol Ther; 2015 May; 53(5):345-55. PubMed ID: 25740267
[TBL] [Abstract][Full Text] [Related]
12. Targeting intestinal transporters for optimizing oral drug absorption.
Varma MV; Ambler CM; Ullah M; Rotter CJ; Sun H; Litchfield J; Fenner KS; El-Kattan AF
Curr Drug Metab; 2010 Nov; 11(9):730-42. PubMed ID: 21189135
[TBL] [Abstract][Full Text] [Related]
13. Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model.
Miller WH; Bondinell WE; Cousins RD; Erhard KF; Jakas DR; Keenan RM; Ku TW; Newlander KA; Ross ST; Haltiwanger RC; Bradbeer J; Drake FH; Gowen M; Hoffman SJ; Hwang SM; James IE; Lark MW; Lechowska B; Rieman DJ; Stroup GB; Vasko-Moser JA; Zembryki DL; Azzarano LM; Adams PC; Huffman WF
Bioorg Med Chem Lett; 1999 Jul; 9(13):1807-12. PubMed ID: 10406646
[TBL] [Abstract][Full Text] [Related]
14. Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin alphavbeta3) antagonists.
Miller WH; Manley PJ; Cousins RD; Erhard KF; Heerding DA; Kwon C; Ross ST; Samanen JM; Takata DT; Uzinskas IN; Yuan CC; Haltiwanger RC; Gress CJ; Lark MW; Hwang SM; James IE; Rieman DJ; Willette RN; Yue TL; Azzarano LM; Salyers KL; Smith BR; Ward KW; Johanson KO; Huffman WF
Bioorg Med Chem Lett; 2003 Apr; 13(8):1483-6. PubMed ID: 12668017
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
